News

Infectious Disease Advisor23h
Combined Influenza, SARS-CoV-2 Vaccine as Effective as Individual Vaccines for Older Adults
RNA-1083 vaccine is noninferior and induces higher immune responses than recommended influenza and COVID-19 vaccines.
StockStory.org on MSN14h
MRNA Q1 Earnings Call: Management Focuses on Cost Reductions and Pipeline Progress Amid Revenue Shortfall
Biotechnology company Moderna (NASDAQ:MRNA) in Q1 CY2025, with sales falling 35.3% year on year to $108 million. The ...